Skip to content
Screener

Strata Critical Medical SRTA Q4 2025 Annual earnings

Reported March 3, 2026 · Before market open

Revenue$66.8MBeat by $6.4M
EPS-$0.06Miss by $0.07
Revenue estimate$60.4M
EPS estimate$0.01

Next report

Nov 9, 2026 (In 3 weeks)
Revenue estimate$72.7M
EPS estimate$0.01

Financials

Q4 2025

Income statement

See full
Revenue$66.8M+83.5%
Gross profit$11.7M+133%
Operating income-$6.4M-8.5%

Balance sheet

See full
Cash & equivalents$31.2M+59.0%
Total debt$3.3M-64.5%
Total equity$279.1M+25.7%
Total assets$325.5M+26.8%

Cash flow

See full
Operating cash flow-$8.3M-374%
CapEx$1.8M-59.6%
Free cash flow-$10.2M-60.5%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$415.42M—
Enterprise value$387.5M—
P/S1.9×—

Profitability

See full
Gross margin21.6%+1.2pp
Operating margin-10.2%-3.1pp
FCF margin-26.3%+27.3pp

Returns & leverage

See full
Debt / equity0×0.0×
Current ratio6.4×-0.7×

FAQ

When did Strata Critical Medical report Q4 2025 earnings?
Strata Critical Medical (SRTA) reported Q4 2025 earnings on March 3, 2026 before market open.
What were Strata Critical Medical's Q4 2025 revenue and EPS?
Strata Critical Medical reported revenue of $66.8M and eps of $-0.06 for Q4 2025.
Did Strata Critical Medical beat estimates in Q4 2025?
Revenue beat the consensus estimate of $60.4M by $6.4M. EPS missed the consensus estimate of $0.01 by $0.07.
How did Strata Critical Medical's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 22.9% from $54.4M a year earlier and eps grew 48.2% from $-0.12.
Where can I find Strata Critical Medical's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001628280-26-013553) and the 10-K periodic report (0001628280-26-013628) directly on SEC EDGAR. The filing index links above go to sec.gov.